Exhibits Complete the diagram by dragging from the choices area to specify which condition the client is most likely experiencing, two actions the nurse should take to address that condition, and two parameters the nurse should monitor to assess the client's progress.

• Drug toxicity: The client’s symptoms headache, dizziness, tachycardia, and ventricular tachycardia are hallmark signs of theophylline toxicity. This medication has a narrow therapeutic window, and toxicity can lead to serious cardiac and CNS effects requiring immediate intervention. • Cardiopulmonary arrest: While ventricular tachycardia can precede cardiopulmonary arrest, the client is not yet in arrest. Immediate management aims to prevent progression, so this is not the primary condition but a potential complication. • Hypovolemic shock: The client has vomiting and diarrhea, which could cause hypovolemia, but vital signs and clinical picture are more consistent with drug toxicity. Hypovolemic shock would present with hypotension and signs of poor perfusion, which are not predominant here. • Allergic reaction: There are no signs of an allergic reaction such as rash, airway swelling, or hypotension. The presentation is not consistent with anaphylaxis or hypersensitivity. • Hold theophylline: Since the client is exhibiting toxicity symptoms, withholding theophylline immediately is essential to prevent worsening toxicity and life-threatening arrhythmias. Continuing the drug could cause further harm. • Assess medication interactions: The recent antibiotic prescription could have interacted with theophylline metabolism, leading to elevated serum levels and toxicity. Reviewing all medications helps identify interactions and prevent recurrence. • Administer albuterol: Albuterol is a bronchodilator for asthma symptoms but does not address the toxicity causing ventricular tachycardia. Administering albuterol may increase heart rate and worsen arrhythmias, so it is not indicated in this emergency. • Assess allergies: While always important, allergy assessment is not the priority here because the symptoms do not indicate an allergic reaction. The client’s presentation suggests toxicity rather than hypersensitivity. • Give a bolus of IV fluids: Although fluid resuscitation is critical for dehydration or hypovolemia, the primary issue is drug toxicity with cardiac arrhythmia, not volume depletion. IV fluids are not the immediate intervention for VT due to theophylline toxicity. • Oxygen saturation: Monitoring oxygen saturation is important to ensure adequate oxygen delivery but does not directly assess drug toxicity or arrhythmia progression. It is supportive but not a primary monitoring parameter here. • Theophylline blood levels: Measuring serum theophylline levels is vital to confirm toxicity severity and guide treatment decisions, including when it is safe to restart therapy or use antidotes. • Respiratory rate: While tachypnea may reflect distress, respiratory rate monitoring alone does not give enough information on cardiac toxicity or drug levels. It supports overall assessment but is less specific. • Serum electrolyte levels: Electrolyte imbalances can worsen arrhythmias, so monitoring them is important, but this is adjunctive in this scenario. The priority is managing drug toxicity and cardiac rhythm. • Cardiac rhythm: Continuous cardiac monitoring is essential to detect and respond to arrhythmias like ventricular tachycardia and evaluate the effectiveness of interventions. This is a critical parameter in toxicity management.